BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30366590)

  • 1. Plaque Psoriasis Flare and Peripheral Edema in a Patient Treated With Atezolizumab.
    Santos-Juanes J; Munguía Calzada P; Álvarez Fernández C
    Actas Dermosifiliogr (Engl Ed); 2019 Jun; 110(5):410-411. PubMed ID: 30366590
    [No Abstract]   [Full Text] [Related]  

  • 2. TNF-α inhibitor (adalimumab) induced psoriasis: a case report.
    Al-Mutairi A; Elkashlan M; Al-Fayed HM; Swayed M
    Australas J Dermatol; 2012 May; 53(2):157. PubMed ID: 22571571
    [No Abstract]   [Full Text] [Related]  

  • 3. Debut Of Inflammatory Bowel Disease Associated To Ixekizumab In Patient With Moderate, Difficult -To-Manage Psoriasis.
    Merino Gallego E; Gómez Torres K; Martínez Amate E
    Gastroenterol Hepatol; 2020 Dec; 43(10):622-623. PubMed ID: 32674878
    [No Abstract]   [Full Text] [Related]  

  • 4. A Case of Ixekizumab-induced Psoriasiform Eruption.
    Oiwa T; Fujita M; Takase S; Nishimura Y; Ota M; Okada K; Tachibana T
    Acta Derm Venereol; 2019 Apr; 99(4):446-447. PubMed ID: 30723870
    [No Abstract]   [Full Text] [Related]  

  • 5. Occurrence of psoriasiform eruption during dupilumab therapy for adult atopic dermatitis: A case series.
    Napolitano M; Scalvenzi M; Fabbrocini G; Cinelli E; Patruno C
    Dermatol Ther; 2019 Nov; 32(6):e13142. PubMed ID: 31664761
    [No Abstract]   [Full Text] [Related]  

  • 6. Psoriasiform dermatitis in a non-psoriatic patient treated with adalimumab.
    Tammaro A; Persechino S; Abruzzese C; Narcisi A; Cortesi G; Parisella FR; Laganà B
    Int J Immunopathol Pharmacol; 2012; 25(2):499-501. PubMed ID: 22697082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onset of psoriasis with psoriatic arthropathy during rituximab treatment of non-Hodgkin lymphoma.
    Mielke F; Schneider-Obermeyer J; Dörner T
    Ann Rheum Dis; 2008 Jul; 67(7):1056-7. PubMed ID: 18556453
    [No Abstract]   [Full Text] [Related]  

  • 8. [Docetaxel-induced psoriasis].
    Allende I; González-Hermosa R; Lázaro M; Díaz-Pérez JL
    Actas Dermosifiliogr; 2009 Sep; 100(7):629-30. PubMed ID: 19715656
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic Significance of Cutaneous Adverse Events Associated With Pembrolizumab Therapy.
    Lo JA; Fisher DE; Flaherty KT
    JAMA Oncol; 2015 Dec; 1(9):1340-1. PubMed ID: 26270186
    [No Abstract]   [Full Text] [Related]  

  • 10. Ocrelizumab-induced psoriasiform dermatitis in a patient with multiple sclerosis.
    Darwin E; Romanelli P; Lev-Tov H
    Dermatol Online J; 2018 Jul; 24(7):. PubMed ID: 30261571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocilizumab-induced psoriasiform rash in rheumatoid arthritis.
    Palmou-Fontana N; Sánchez Gaviño JA; McGonagle D; García-Martinez E; Iñiguez de Onzoño Martín L
    Dermatology; 2014; 228(4):311-3. PubMed ID: 24942661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psoriasis-like eruption induced by adalimumab in a patient with rheumatoid arthritis : a case report and review of literature].
    Kuno H; Kotani T; Takeuchi T; Wakura D; Wakura R; Yu A; Makino S; Moriwaki S; Hanafusa T
    Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(6):520-5. PubMed ID: 23291487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of new-onset psoriasis while on anti-TNFalpha treatment.
    Matthews C; Rogers S; FitzGerald O
    Ann Rheum Dis; 2006 Nov; 65(11):1529-30. PubMed ID: 17038454
    [No Abstract]   [Full Text] [Related]  

  • 14. Diffuse psoriasis induced by docetaxel in a 62-year-old woman with breast carcinoma.
    Mapelli ET; Gualandri L; Menni S; Cerri A
    G Ital Dermatol Venereol; 2016 Jun; 151(3):309-10. PubMed ID: 27176084
    [No Abstract]   [Full Text] [Related]  

  • 15. Cutaneous hemophagocytosis after alemtuzumab injection in a patient with Sézary syndrome.
    Jawed SI; Busam K; Wang X; Horwitz S; Querfeld C
    JAMA Dermatol; 2014 Sep; 150(9):1021-3. PubMed ID: 25029560
    [No Abstract]   [Full Text] [Related]  

  • 16. Ustekinumab treatment of TNF antagonist-induced paradoxical psoriasis flare in a patient with psoriatic arthritis: case report and review.
    Puig L; Morales-Múnera CE; López-Ferrer A; Geli C
    Dermatology; 2012; 225(1):14-7. PubMed ID: 22890275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New-onset psoriasis induced by rituximab therapy for non-Hodgkin lymphoma in a child.
    Kim DW; Park SK; Woo SH; Yun SK; Kim HU; Park J
    Eur J Dermatol; 2016 Apr; 26(2):190-1. PubMed ID: 26771919
    [No Abstract]   [Full Text] [Related]  

  • 18. Sorafenib-induced annular pustular psoriasis (Milian-Katchoura type).
    Du-Thanh A; Girard C; Pageaux GP; Guillot B; Dereure O
    Eur J Dermatol; 2013; 23(6):900-1. PubMed ID: 24184416
    [No Abstract]   [Full Text] [Related]  

  • 19. Is cetuximab-induced rash conclusion really a remnant of the skin erythema dose?
    Oskan F; Belka C; Manapov F
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):462-3. PubMed ID: 24074919
    [No Abstract]   [Full Text] [Related]  

  • 20. Generalized exacerbation of psoriasis associated with imiquimod cream treatment of superficial basal cell carcinomas.
    Rajan N; Langtry JA
    Clin Exp Dermatol; 2006 Jan; 31(1):140-1. PubMed ID: 16309513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.